12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Chembio Diagnostics (NASDAQ:CEMI) shares increased by 26.4% to $1.1 during Tuesday's pre-market session. The market value of their outstanding shares is at $33.2 million.
• Femasys (NASDAQ:FEMY) shares rose 21.78% to $2.46. The market value of their outstanding shares is at $29.0 million. The company's, Q2 earnings came out 4 days ago.
• Organovo Holdings (NASDAQ:ONVO) shares moved upwards by 15.13% to $3.5. The market value of their outstanding shares is at $30.4 million.
• ANI Pharmaceuticals (NASDAQ:ANIP) shares increased by 13.63% to $43.0. The company's market cap stands at $749.3 million.
• Mainz Biomed (NASDAQ:MYNZ) stock rose 13.63% to $10.5. The market value of their outstanding shares is at $144.2 million.
• OKYO Pharma (NASDAQ:OKYO) shares moved upwards by 11.32% to $2.36. The market value of their outstanding shares is at $51.3 million.

Losers

• Albireo Pharma (NASDAQ:ALBO) shares fell 22.8% to $19.25 during Tuesday's pre-market session. The company's market cap stands at $376.8 million. As per the news, the Q2 earnings report came out yesterday.
• T2 Biosystems (NASDAQ:TTOO) stock declined by 19.11% to $0.17. The company's market cap stands at $28.5 million. The company's, Q2 earnings came out yesterday.
• Sema4 Holdings (NASDAQ:SMFR) shares declined by 15.84% to $2.02. The market value of their outstanding shares is at $762.0 million. The company's, Q2 earnings came out yesterday.
• MiNK Therapeutics (NASDAQ:INKT) stock declined by 14.71% to $2.9. The company's market cap stands at $97.3 million.
• SomaLogic (NASDAQ:SLGC) shares fell 9.93% to $3.72. The market value of their outstanding shares is at $678.1 million. The company's, Q2 earnings came out yesterday.
• Ayala Pharmaceuticals (NASDAQ:AYLA) stock fell 9.61% to $1.13. The market value of their outstanding shares is at $15.9 million. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.